The Effect of Tecfidera (Dimethyl Fumarate, BG00012) on the Gut Microbiota as a Causal Factor for Gastro Intestinal Associated Adverse Events.
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2016
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Biogen
- 22 Nov 2016 Planned End Date changed from 1 Feb 2017 to 1 Jun 2017.
- 22 Nov 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Jun 2017.
- 11 Apr 2016 Planned End Date changed from 1 Oct 2016 to 1 Feb 2017 as reported by ClinicalTrials.gov.